CBN (cannabinol)

 

Studies are beginning to show that is minor cannabinoid has the potential to aid with ADHD and eye issues. As always, please consult your doctors prior to beginning a cannabis regimen.

 

Antibacterial cannabinoids from Cannabis sativa: a structure-activity study

Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival  

Cannabinol and cannabidiol exert opposing effects on rat feeding patterns

Synthesis and Pharmacological Effects of Mice of Halogenated Cannabinol Derivatives

Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or Cannabigerol

Δ9-Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism

Cannabinol is a cannabinoid isolated from the plant Cannabis that is a metabolite of tetrahydrocannabinol (THC), with potential immunosuppressive and anti-inflammatory activities.

Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

Current research into the potential therapeutic effects of cannabinol (CBN)

Cannabinol (CBN): Ever Present But Underappreciated

Research Shows 9 Potential Health Benefits of CBN

Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma

Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review

Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo